$PPIH

Perma-Pipe Reports Lower Q1 Profit, Shares Down

Perma-Pipe International Holdings (PPIH) reported first-quarter 2026 net income of $2.59 million, down from $5.85 million a year earlier, despite higher net sales of $50.27 million versus $46.75 million. The company attributed the profit decline to product mix across jurisdictions and higher expenses; operating expenses rose to $10.0 million from $8.84 million. EPS fell to $0.22 from $0.61. Shares were down 16.13% at $26.22 on Nasdaq.

Original reporting
Published Jun 9, 2026, 5:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 5:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Perma-Pipe Reports Lower Q1 Profit, Shares Down — source image
Decision brief

The 30-second read

$PPIHBearishMed
01

Why it matters

The disclosed margin deterioration (higher operating expenses and unfavorable product mix) is likely the core driver behind the reported ~16% share decline and will influence expectations for subsequent quarters.

02

Market read

A company-specific earnings print with concrete P&L figures and an explicit explanation for the profit decline.

03

What to watch

The article doesn’t provide guidance, cash flow, backlog, or segment detail—traders may be overreacting to profit alone without seeing forward indicators.

Relevance 7/10Novelty 8/10Timing: after-hours/next-session reaction to Q1 2026 results

Background

Perma-Pipe’s Q1 2026 results show revenue growth but a sharp year-over-year drop in net income and EPS.

Company-level read

Ticker impact

$PPIHBearishHigh confidence
Context

Perma-Pipe reported Q1 2026 net income fell to $2.59M (from $5.85M) despite higher net sales, with EPS down to $0.22.

Expected impact

Bearish bias; traders may fade rallies or reduce exposure until margin drivers stabilize.

Evidence & confidence

The article discloses the quarter’s profit/EPS decline and cites specific causes (product mix, higher expenses), which typically drives immediate repricing versus prior-year comparisons.

Market effects

Signals potential margin pressure in niche industrial piping suppliers when product mix shifts and operating costs rise.

No specific regional demand signal provided; impact appears company-specific across jurisdictions.

Limited—no guidance, backlog, or macro drivers disclosed beyond mix/expense commentary.

Counterpoint

Higher net sales alongside lower profit could mean demand remains intact, and the earnings miss may be temporary if mix normalizes.

Key entities

  • Perma-Pipe International Holdings, Inc.

    Reported Q1 2026 net income and EPS decline despite higher net sales; shares down ~16% per article.

Related articles

$AEONMed

System failure at major Japanese frozen food company disrupts supply chains

Nichirei Corp said a system failure tied to unauthorized access began disrupting its frozen food shipments and refrigerated warehouse operations. The company, serving about 5,000 business clients, plans a gradual restart from Friday but gave no full recovery timeline and flagged possible personal data exposure. KFC Japan, Kura Sushi, Aeon subsidiaries, Don Quijote operator Pan Pacific, Ezaki Glico, and Imuraya reported ingredient shortages.

$PPIHMed

Perma-Pipe International Holdings, Inc. (PPIH): Results of Operations and Financial Condition

Perma-Pipe International Holdings, Inc. (PPIH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_960423.htm EXHIBIT 99.1 ex_960423.htm Exhibit 99.1 COMPANY: Perma-Pipe International Holdings, Inc. CONTACT: Saleh Sagr, President, Chief Executive Officer, and Director Perma-Pipe Investor Relations (281) 941-2445 investor@permapipe.com Perma-Pipe International Hold

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.

$LIONMed

Lionsgate Studios Q1 Earnings Call Highlights

Lionsgate (NYSE:LION) Q1 earnings call said it expects downstream revenue from films through fiscal 2027 and that The Hunger Games: Sunrise on the Reaping could support later-year results. Television revenue was $189 million, segment profit $10 million. Trailing 12-month library revenue was $987 million, backlog $1.5 billion. Net debt fell $121 million to about $1.5 billion; leverage improved to 4.3x.

$ENBMed

Enbridge Delivers Strong Q2 Results: Is the Stock Still a Buy?

Enbridge reported Q2 2026 results, with adjusted earnings of $1.4B, or $0.63 per share, roughly matching last year’s $0.65. Adjusted EBITDA rose to $4.8B from $4.6B. Operating cash flow increased to $4.1B from $3.2B. The company reaffirmed full-year guidance, added $1B to a $41B growth backlog, sanctioned Line 5 relocation and signed an option for the TTC Connector Pipeline.